Almotriptan 12.5 mg in menstrually related migraine: a randomized, double-blind, placebo-controlled study. - Wikidata - awgldk - TriplyDB

Almotriptan 12.5 mg in menstrually related migraine: a randomized, double-blind, placebo-controlled study.

Almotriptan 12.5 mg in menstrually related migraine: a randomized, double-blind, placebo-controlled study.

http://www.wikidata.org/entity/Q34673690

about

Efficacy of zolmitriptan nasal spray in management of acute migraine Systematic Review of Preventive and Acute Treatment of Menstrual Migraine.Frovatriptan versus almotriptan for acute treatment of menstrual migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study A review of the use of frovatriptan in the treatment of menstrually related migraine.Almotriptan for menstrually related migraine.Triptans: over the migraine.Treatment of perimenstrual migraine with triptans: an update.Menstrual migraine: an updated review on hormonal causes, prophylaxis and treatment.Comparative tolerability of treatments for acute migraine: A network meta-analysis.Triptans and migraine: advances in use, administration, formulation, and development.Menstrual Migraine and Treatment Options: Review.Comparing the efficacy of eletriptan for migraine in women during menstrual and non-menstrual time periods: a pooled analysis of randomized controlled trials.Menstrual migraine: a review of current and developing pharmacotherapies for women.Pharmacokinetic evaluation of almotriptan for the treatment of migraines.Treatment strategies for menstrually related migraine.

P2860

Q33979686-4C201518-E53B-467E-9078-999ADC8EA65A Q35742998-A9782D29-C6E9-4D01-A9B1-64DA37F7121A Q36052155-D9A748D5-B30C-4EC9-AF44-C455CF02B161 Q36638660-83392D27-E922-424C-917E-C4AE68A1FE01 Q37897224-9F0C855C-539D-42F2-9153-6C2C433AE735 Q38014303-66618D1C-ED00-4115-AE3D-A24445FE9B9D Q38014363-CB2847BA-EFB7-407F-A33D-157C52703989 Q38237616-3A3A762E-645C-4C35-ABEF-2ED2C40A8D66 Q38927015-50AF5106-03B9-456E-8377-8F72A089D287 Q38994955-A1967241-E64D-4097-B6B8-9F2840E39D75 Q39026779-6275A342-A56D-42F8-9AC3-84388213DDF8 Q45995793-66DD8677-9EEC-4998-9C5B-096F172DC661 Q50047547-B595AA5C-1DBE-42A1-960D-7825C3ED739F Q50490563-AE47818E-935D-45BC-BB0B-DAA8F84171C8 Q51314345-61D9FD42-D704-41B9-A5EF-1FF19426709D

P2860

Almotriptan 12.5 mg in menstrually related migraine: a randomized, double-blind, placebo-controlled study.

http://www.wikidata.org/entity/Q34673690

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Almotriptan 12.5 mg in menstru ...... ind, placebo-controlled study.

@ast

Almotriptan 12.5 mg in menstru ...... ind, placebo-controlled study.

@en

Almotriptan 12.5 mg in menstru ...... ind, placebo-controlled study.

@nl

type

label

Almotriptan 12.5 mg in menstru ...... ind, placebo-controlled study.

@ast

Almotriptan 12.5 mg in menstru ...... ind, placebo-controlled study.

@en

Almotriptan 12.5 mg in menstru ...... ind, placebo-controlled study.

@nl

prefLabel

Almotriptan 12.5 mg in menstru ...... ind, placebo-controlled study.

@ast

Almotriptan 12.5 mg in menstru ...... ind, placebo-controlled study.

@en

Almotriptan 12.5 mg in menstru ...... ind, placebo-controlled study.

@nl

P1433

Q34673690-A247F381-AB60-4E6B-A59C-2C39B8CB65EE

P1476

Q34673690-F7C58C6F-52E8-4B9A-99E3-9A5814197B38

P2093

Q34673690-2ACF4970-BA8C-4BB4-9F5D-843264C42ABC

Q34673690-41242153-37E5-42AB-8F13-A8A9F5B64198

Q34673690-4BF10F66-18B3-42D2-ADBD-678114C0422E

Q34673690-9E943DC6-5514-4FD1-BFAA-AEF3E7319096

Q34673690-A7657748-E57B-4E57-83B1-728EFAB54FC6

Q34673690-B620A13B-33BE-41C5-BC06-C82CAD4A6E8E

Q34673690-E4206F30-B735-4BFD-B2D2-071D3004C0E2

P2860

Q34673690-072AC30E-C76E-45E2-A79E-D4FEF9B003C6

Q34673690-30E32A53-0E31-4E43-9C54-38A083592FBE

Q34673690-338A74E0-F19E-4009-AA6E-2E1FB2E97DB8

Q34673690-37EF8E6C-EBAE-49B2-A415-F6AE85154272

Q34673690-494AB12A-6534-49D7-BFA9-FB6AAECC19AB

Q34673690-59CDC5A5-CC2A-4589-AA88-6C6D3D811BCB

Q34673690-8C17E578-6E2D-4C27-BE99-3249AA2D7DD8

Q34673690-D9883BC4-A343-44BD-B1B1-8FBF65F1727C

Q34673690-DB69C22C-50A1-45EC-B975-F0AD27222031

Q34673690-E44C5A64-D6CB-4FD7-A8B2-9A93748B8C12

P304

Q34673690-C05B1CFA-6476-4B35-909A-70ECD9F19EC3

P31

Q34673690-643573B0-BC65-487E-B2D6-B315289FC796

P356

Q34673690-E26DAA2C-D653-421B-A83F-35B85D974A93

P407

Q34673690-E10AE149-D6B2-49DE-8789-DA9373BD5242

P433

Q34673690-83338C9F-E1D9-468E-9428-34F4EA6E55B3

P478

Q34673690-CEB47135-E039-4D59-BD05-BBFEB8D37945

P50

Q34673690-51BF8932-15D3-41CC-9E30-55FD16365BC7

Q34673690-A1916CBC-66E5-4352-893F-DC7F23935AC7

Q34673690-B4BCA5A2-76DF-403B-A35F-660C2582E873

Q34673690-FEEC949E-1269-4BB9-9166-284E7804E994

P577

Q34673690-9BB3807F-B7E9-4B77-9390-359D2405A3B2

P5875

Q34673690-98B87BD9-B829-4511-A9D0-A7C2BA0C1678

P698

Q34673690-FF2FECC9-A132-4B57-9888-451AC2AB1313

P921

Q34673690-53BC161D-2666-4B92-B9BB-8BB68334D9C2

Q34673690-6DD48601-795D-4625-8AE3-D32F57ECBE7C

Q34673690-B86027EA-13A3-4ADA-83EE-714390FC78CF

P932

Q34673690-AF9B337B-6E95-409B-8AFA-FBF8B83DE91B

P356

0333102410378048

P1433

P1476

Almotriptan 12.5 mg in menstru ...... ind, placebo-controlled study.

@en

P2093

Fabio Valguarnera

http://www.w3.org/2001/XMLSchema#string

Florindo d'Onofrio

http://www.w3.org/2001/XMLSchema#string

Franca Moschiano

http://www.w3.org/2001/XMLSchema#string

Gian Camillo Manzoni

http://www.w3.org/2001/XMLSchema#string

Giancarlo Acuto

http://www.w3.org/2001/XMLSchema#string

Giovanni D'Andrea

http://www.w3.org/2001/XMLSchema#string

Rita Allais

http://www.w3.org/2001/XMLSchema#string

P2860

The International Classification of Headache Disorders: 2nd edition

Efficacy, speed of action and tolerability of almotriptan in the acute treatment of migraine: pooled individual patient data from four randomized, double-blind, placebo-controlled clinical trials.

Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centres.

Ovarian hormones and migraine headache: understanding mechanisms and pathogenesis--part 2.

Central sensitization theory of migraine: clinical implications.

Menstrual migraine: a clinical review.

Diagnosis and treatment of the menstrual migraine patient.

Characteristics of migraine attacks and responses to almotriptan treatment: a comparison of menstrually related and nonmenstrually related migraines.

Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).

Efficacy and tolerability of almotriptan versus zolmitriptan for the acute treatment of menstrual migraine.

P304

144-151

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0333102410378048

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

Chiara Benedetto

Gennaro Bussone

P577

2010-07-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45366145

http://www.w3.org/2001/XMLSchema#string

P698

20660540

http://www.w3.org/2001/XMLSchema#string

P921

Amzerioù (merc'hed)

migraine disorder

P932

3057443

http://www.w3.org/2001/XMLSchema#string